Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status

Overview of attention for article published in Oncotarget, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news: 3 news outlets
twitter: 2 X users

facebook: 1 Facebook page
video: 1 YouTube creator

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 20 Mendeley

Summary News X Facebook YouTube Dimensions citations

So far, Altmetric has seen 1 public wall post.

Oncotarget, 03 Sep 2021

#PaperoftheDay: "Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple…